Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.
Imprese · 10/10/20241 min di lettura
Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Final Guidance
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Centers for Medicare & Medicaid Services (CMS) is announcing the availability of CMS' final guidance for the second cycle of the Medicare Drug Price Negotiation Program and manufacturer effectuation of the maximum fair price in 2026 and 2027 for the implementation of the Inflation Reduction Act. This and other Inflation Reduction Act-related guidance can be viewed on the dedicated Inflation Reduction Act section of the CMS website at https://www.cms.gov/ inflation-reduction-act-and-medicare/.
Lingua originale della fonte: Federal Register — Health and Human ServicesApri il comunicato originale →